Financial Avengers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.2K | Buy |
134
+2
| +2% | +$93 | ﹤0.01% | 119 |
|
|
2025
Q1 | $8.07K | Buy |
132
+1
| +0.8% | +$61 | ﹤0.01% | 117 |
|
|
2024
Q4 | $7.41K | Buy |
131
+1
| +0.8% | +$57 | ﹤0.01% | 131 |
|
|
2024
Q3 | $6.71K | Buy |
130
+2
| +2% | +$103 | ﹤0.01% | 145 |
|
|
2024
Q2 | $5.32K | Buy |
128
+2
| +2% | +$83 | ﹤0.01% | 130 |
|
|
2024
Q1 | $6.69K | Buy |
126
+1
| +0.8% | +$53 | ﹤0.01% | 118 |
|
|
2023
Q4 | $6.4K | Buy |
125
+2
| +2% | +$102 | ﹤0.01% | 130 |
|
|
2023
Q3 | $7.16K | Buy |
123
+1
| +0.8% | +$58 | ﹤0.01% | 125 |
|
|
2023
Q2 | $7.82K | Buy |
122
+1
| +0.8% | +$64 | 0.01% | 115 |
|
|
2023
Q1 | $8.4K | Buy |
121
+1
| +0.8% | +$69 | 0.01% | 115 |
|
|
2022
Q4 | $8.66K | Buy |
120
+1
| +0.8% | +$72 | 0.01% | 110 |
|
|
2022
Q3 | $8K | Hold |
119
| – | – | 0.01% | 105 |
|
|
2022
Q2 | $9K | Buy |
119
+1
| +0.8% | +$76 | 0.01% | 112 |
|
|
2022
Q1 | $9K | Buy |
118
+1
| +0.9% | +$76 | 0.01% | 118 |
|
|
2021
Q4 | $7K | Buy |
117
+1
| +0.9% | +$60 | ﹤0.01% | 130 |
|
|
2021
Q3 | $7K | Buy |
116
+1
| +0.9% | +$60 | ﹤0.01% | 127 |
|
|
2021
Q2 | $8K | Buy |
115
+1
| +0.9% | +$70 | 0.01% | 124 |
|
|
2021
Q1 | $7K | Buy |
114
+1
| +0.9% | +$61 | 0.01% | 129 |
|
|
2020
Q4 | $7K | Buy |
+113
| New | +$7K | 0.01% | 126 |
|